Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sanofi ADR

SAN
Current price
92.43 EUR -1.48 EUR (-1.58%)
Last closed 51.33 USD
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Euronext Paris
Capitalization 126 804 402 176 USD
Yield for 12 month -5.18 %
1Y
3Y
5Y
10Y
15Y
SAN
21.11.2021 - 28.11.2021

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. Address: 46, avenue de la Grande Armée,, Paris, France, 75017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

59.89 USD

P/E ratio

25.8571

Dividend Yield

3.97 %

Current Year

+46 909 801 829 USD

Last Year

+49 435 546 673 USD

Current Quarter

+12 109 198 438 USD

Last Quarter

+24 923 078 599 USD

Current Year

+28 860 365 193 USD

Last Year

+34 519 602 024 USD

Current Quarter

+8 363 602 699 USD

Last Quarter

+15 052 088 722 USD

Key Figures SAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 12 199 499 776 USD
Operating Margin TTM 18.28 %
PE Ratio 25.8571
Return On Assets TTM 4.54 %
PEG Ratio 0.8375
Return On Equity TTM 7.27 %
Wall Street Target Price 59.89 USD
Revenue TTM 46 287 998 976 USD
Book Value 59.17 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 2.3 %
Dividend Yield 3.97 %
Gross Profit TTM 31 697 000 000 USD
Earnings per share 1.96 USD
Diluted Eps TTM 1.96 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -43.2 %
Profit Margin 9.8 %

Dividend Analytics SAN

Dividend growth over 5 years

2 %

Continuous growth

1 year

Payout Ratio 5 years average

71 %

Dividend History SAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 2.04
Ex Dividend Date 09.05.2024
Forward Annual Dividend Yield 3.97 %
Last Split Factor 5:1
Payout Ratio 36.5 %
Last Split Date 30.09.2013
Dividend Date 06.06.2024

Stock Valuation SAN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 25.8571
Forward PE 11.1359
Enterprise Value Revenue 2.7108
Price Sales TTM 2.5237
Enterprise Value EBITDA 9.9891
Price Book MRQ 1.4441

Financials SAN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SAN

For 52 weeks

42.63 USD 55.72 USD
50 Day MA 48.96 USD
Shares Short Prior Month 7 819 626
200 Day MA 48.81 USD
Short Ratio 3.66
Shares Short 8 067 561
Short Percent 0.32 %

Dynamics of changes in the value of assets

C

CBAPJ

103.43 AUD Commonwealth Bank of Australia Preferred +0.12 (+0.16%)
Detailed analytics
C

CBAPI

104.50 AUD Commonwealth Bank of Australia Preferred +0.08 (+0.11%)
Detailed analytics
TJX

TJX

104.24 EUR The TJX Companies Inc -0.54 (-0.48%)
Detailed analytics
TJX

TJX

113.81 USD The TJX Companies Inc -0.48 (-0.42%)
Detailed analytics
D

DTEA

23.80 EUR Deutsche Telekom AG +0.44 (+1.71%)
Detailed analytics